Estarylla Kit
Product Images NDC 82804-158

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Estarylla (NDC 82804-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pregnancy Risk Chart (Chart)

A vertical efficacy chart illustrating pregnancy rates per 100 women in one year related to contraceptive methods. The chart ranks methods from most effective at the top with fewer than 1 pregnancy per 100 women (implants, injections, intrauterine devices, sterilization) to least effective at the bottom with 85 or more pregnancies (no birth control). Intermediate methods include birth control pills, skin patch, vaginal ring, condoms, diaphragm, and behavioral methods.*

FDA Label Image

Estarylla-blister-new.jpg (Estarylla Blister)

Estarylla kit containing Norgestimate and Ethinyl Estradiol tablets, each with 0.25 mg of Norgestimate and 0.035 mg of Ethinyl Estradiol. The image shows a four-week calendar blister pack with circular tabs labeled by day of the week for daily oral administration, produced by Proficient Rx LP.*

FDA Label Image

Figure 2 (Figure 2)

A forest plot chart showing effect estimates (odds ratios or relative risks) with confidence intervals from multiple studies related to women's contraceptive use, including the NICHD Women's Contraceptive Study, French E3N cohort, Shanghai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The x-axis represents the effect estimate (OR/RR), ranging from -1.5 to 2, with a central value of 1 indicating no effect.*

FDA Label Image

82804-158-28 (Image 01)

Label for Estarylla containing norgestimate and ethinyl estradiol tablets in a 28-day supply. Label shows the product is prescription only and indicates 28 day tablets with each tablet's content referenced to the package insert. The manufacturer is Laboratorios León Farma S.A., Spain. The label includes storage instructions and multiple instances of the NDC 82804-158-28.*

FDA Label Image

Ethinyl Estradiol Structure (Structure Ee)

Chemical structure diagram of ethinyl estradiol, showing its molecular framework with labeled chemical groups as part of the active ingredients in Estarylla.*

FDA Label Image

Norgestimate Structure (Structure Norgestimate)

Chemical structure diagram of Norgestimate, an active ingredient in Estarylla. The structure shows the steroid framework with labeled functional groups including an acetoxy group and an ethinyl substituent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.